NASDAQ : LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock — SEC Filings

$3.41 USD

$1.55 (83.33%)

Volume
78.85M
Average Volume
298.86K
Market Capitalization
$1.6M
P/E Ratio
Dividend Yield
%
Price Target
Year High
$9.26
Year Low
$0.37
Day High
—
Day Low
—
Payout Ratio
Current Ratio
LABT SEC Filings
Company Symbol Filed Form Type View
LABT 2026-07-15 16:15:21 8-K
LABT 2026-06-23 11:10:05 SC 13G
LABT 2026-06-22 16:11:56 424B3
LABT 2026-06-22 16:10:35 424B3
LABT 2026-06-17 11:40:39 8-K
LABT 2026-05-26 16:06:53 424B3
LABT 2026-05-26 16:06:16 424B3
LABT 2026-05-22 16:55:07 10-Q
LABT 2026-05-14 16:18:14 424B4
LABT 2026-05-14 00:15:38 EFFECT
LABT 2026-05-06 18:20:17 4
LABT 2026-05-06 18:19:02 3
LABT 2026-05-01 18:31:57 3
LABT 2026-05-01 17:45:43 3
LABT 2026-05-01 17:45:14 3
LABT 2026-05-01 17:44:49 3
LABT 2026-05-01 16:05:32 S-1
LABT 2026-04-30 16:20:52 424B3
LABT 2026-04-28 16:15:18 8-K
LABT 2026-04-23 16:48:24 424B4
LABT 2026-04-22 16:31:10 CERT
LABT 2026-04-20 00:15:22 EFFECT
LABT 2026-04-17 13:30:01 8-A12B
LABT 2026-04-06 11:38:04 S-1/A
LABT 2026-04-01 06:20:52 S-1/A
LABT 2026-03-11 16:45:42 S-1/A
LABT 2026-02-12 21:56:12 S-1/A
LABT 2026-02-04 21:35:12 S-1/A
LABT 2026-01-09 17:28:08 S-1
LABT 2025-10-17 21:07:22 DRS/A
LABT 2025-07-31 21:23:32 DRS